| # | Drug | Count |
|---|---|---|
| 0 | FULVESTRANT | 47 |
| 1 | LETROZOLE | 45 |
| 2 | RIBOCICLIB | 39 |
| 3 | EVEROLIMUS | 27 |
| 4 | ANASTROZOLE | 26 |
| 5 | LETROZOLE TABLETS | 26 |
| 6 | EXEMESTANE | 24 |
| 7 | ANASTROZOLE TABLETS | 20 |
| 8 | OCTREOTIDE ACETATE | 20 |
| 9 | CAPECITABINE | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COUMARIN | 2 | 0.0122 |
| 1 | LULICONAZOLE | 1 | 0.0057 |
| 2 | FULVESTRANT | 47 | 0.0014 |
| 3 | AMIFOSTINE | 1 | 0.0012 |
| 4 | RIBOCICLIB | 39 | 0.0012 |
| 5 | AMILORIDE HYDROCHLORIDE | 1 | 0.0012 |
| 6 | EXEMESTANE | 24 | 0.0011 |
| 7 | FLUTAMIDE | 1 | 0.0010 |
| 8 | ANASTROZOLE TABLETS | 20 | 0.0009 |
| 9 | ERLOTINIB HYDROCHLORIDE | 11 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 58 |
| 1 | Kinase Inhibitor [EPC] | 53 |
| 2 | Estrogen Receptor Antagonist [EPC] | 47 |
| 3 | mTOR Inhibitor Immunosuppressant [EPC] | 27 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 23 |
| 5 | Platinum-based Drug [EPC] | 22 |
| 6 | Microtubule Inhibitor [EPC] | 18 |
| 7 | Alkylating Drug [EPC] | 15 |
| 8 | Corticosteroid [EPC] | 15 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 47 | 0.0012 |
| 1 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |
| 2 | Aromatase Inhibitor [EPC] | 58 | 0.0005 |
| 3 | Calcitonin [EPC] | 1 | 0.0003 |
| 4 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 5 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 6 | Programmed Death Ligand-1 Blocker [EPC] | 4 | 0.0002 |
| 7 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 8 | Cannabinoid [EPC] | 1 | 0.0001 |
| 9 | Anticholinergic [EPC] | 2 | 0.0001 |